Skip to content
LogiclyLogicly

Free for 14 days. No card to start.

Get started free

Z19 Hormone sensitivity malignancy status

Z19 is the ICD-10-CM code family for Hormone sensitivity malignancy status: 2 codes, none of which can lead a home health claim.

Codes in family

2

Can lead a claim

0

Cannot lead a claim

2

What CMS assigns to Z19

None of the 2 codes is assigned a clinical group. None of the 2 is assigned a comorbidity subgroup. None can lead a claim. CMS attaches a code-first note to all 2.

Code first

CMS grouper convention 12, on all 2 codes. Code first:

  • underlying disease

Every code in Z19

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
Z19.1Hormone sensitive malignancy statusCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone
Z19.2Hormone resistant malignancy statusCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone

Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.